Neuland Laboratories Ltd. (NEULANDLAB) Share Price Rises 4.53% Today

Neuland Laboratories Ltd. Share Price rises 4.53% today, reaching Rs 19,713.55 with a market cap of Rs 24,345.23 Cr.

Neuland Laboratories Ltd. Share Price has recorded a notable increase of 4.53% today, closing at Rs 19,713.55. This significant price rise positions the company within the Large Cap category, boasting a market capitalisation of Rs 24,345.23 crore. The stock opened at Rs 18,980 and reached a high of Rs 19,772.45 during the trading session. 5%.

The healthcare sector, where Neuland Laboratories operates, has been witnessing dynamic shifts, and today's price action reflects the company's position within this evolving landscape. While the data confirms the price rise, it does not establish a specific catalyst for this movement. Investors are keenly observing the stock's performance, considering both technical and fundamental factors that may influence its trajectory.

Neuland Laboratories Ltd. (NEULANDLAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 19,713.55
Previous Close	Rs 18,859.8
Today's Change	+Rs 853.75 (+4.53%)
Day Open	Rs 18,980
Day High	Rs 19,772.45
Day Low	Rs 18,980
Current Volume (BSE)	831
BSE Traded Volume	831
NSE Traded Volume	35,537
Combined NSE + BSE Volume	36,368
Turnover	Rs 1.64 crore
Market Capitalisation	Rs 24,345.23 crore
Market Cap Category	Large Cap

Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 19,713.55. versus the previous close of Rs 18,859.8, a rise of 4.53%. The stock opened at Rs 18,980, reached Rs 19,772.45, touched Rs 18,980. Reported volume was 831.

Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 24,345.23 crore

Neuland Laboratories Ltd. holds a market capitalisation of Rs 24,345.23 crore, positioning it as a prominent player in the healthcare sector. The company's valuation metrics, such as P/E and P/B ratios, are crucial for investors assessing its financial health and growth potential. The healthcare sector's benchmark median P/E is 26.44, with an average of 87.62, providing a context for evaluating Neuland's valuation.

The company's market cap significantly exceeds the sector's median and average, highlighting its substantial presence in the industry. Investors are likely to consider these factors when evaluating the stock's potential for future growth and profitability.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.44x
Benchmark Average P/E	87.62x
Benchmark P/E Range	3.61x to 3,439.3x
Benchmark Median P/B	1.9x
Benchmark Median ROE	11.07%
Benchmark Median ROCE	13.24%
Company Market Capitalisation	Rs 24,345.23 crore
Benchmark Median Market Cap	Rs 140.64 crore

Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The healthcare sector, encompassing pharmaceuticals and drugs, is a dynamic and competitive landscape. Neuland Laboratories Ltd. operates within this sector, which includes 198 companies. The sector's benchmark P/E median is 26.44, with an average of 87.62, indicating a wide range of valuations among peers. The P/B median is 1.9, with an average of 2.55, reflecting the sector's asset valuations.

Neuland Laboratories' market capitalisation of Rs 24,345.23 crore places it well above the sector's median and average, underscoring its significant market presence. The sector's ROE median is 11.07%, with an average of 15.18%, while the ROCE median is 13.24%, with an average of 17.64%. These benchmarks provide a context for evaluating Neuland's financial performance relative to its peers.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,921.65	29.31	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,815.27	39.89	8.12	28.21	26.35
Hikal Ltd.	HIKAL	2,738.51	0	2.23	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,653.99	0	3.04	0	5.36
Sai Parenteral's Ltd.	SAIPARENT	2,476.69	169.37	3.13	13.9	12.97

Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 24,345.23 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

In the healthcare sector, Neuland Laboratories Ltd. competes with several notable peers. Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,921.65 crore, with a P/E of 29.31 and a P/B of 0.43. Kwality Pharmaceuticals Ltd. boasts a market cap of Rs 2,815.27 crore, with a P/E of 39.89 and a P/B of 8.12. Hikal Ltd. has a market cap of Rs 2,738.51 crore, with a P/B of 2.23.

Neuland Laboratories' market cap significantly exceeds these peers, highlighting its dominant position in the sector.

Why Investors Are Watching Neuland Laboratories Ltd.

Investors are closely monitoring Neuland Laboratories Ltd. due to its recent price rise and market position. The company's performance in the healthcare sector, coupled with its substantial market capitalisation, makes it a focal point for analysis.

• Price Action: Significant 4.53% rise today.
• Market Position: Large Cap with Rs 24,345.23 crore market cap.
• Sector Context: Operates in a dynamic healthcare sector.

Investors should continue to track Neuland Laboratories' performance, considering both market trends and company-specific developments that may influence its future trajectory.

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. is a key player in the healthcare sector, focusing on pharmaceuticals and drugs. The company operates within a competitive industry, leveraging its expertise to deliver high-quality products. Its substantial market capitalisation of Rs 24,345.23 crore underscores its significant presence in the market.

Neuland Laboratories' operations are aligned with the dynamic shifts in the healthcare sector, positioning it as a prominent entity within the industry. The company's focus on innovation and quality continues to drive its growth and market relevance.

Track Neuland Laboratories Ltd. Share Price on Univest

Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Neuland Laboratories Ltd. Share Price on Univest, accessing live updates on price movements, technical indicators, and fundamental ratios. Univest provides comprehensive insights into the company's shareholding pattern, 52-week levels, and market trends, enabling informed investment decisions.

Frequently Asked Questions

What is the current share price of Neuland Laboratories Ltd.?

Ans. The current share price of Neuland Laboratories Ltd. is Rs 19,713.55, reflecting a 4.53% increase from the previous close of Rs 18,859.80. The stock moved 4.53% during the session. The intraday range extended from Rs 18,980 to Rs 19,772.45.

How much did Neuland Laboratories Ltd. share price rise today?

Ans. Neuland Laboratories Ltd. share price rose by 4.53% today, marking a significant increase in the stock's value. The stock moved 4.53% during the session. The intraday range extended from Rs 18,980 to Rs 19,772.45.

How does Neuland Laboratories Ltd. compare with its peers?

Ans. Neuland Laboratories Ltd. has a higher market cap than peers like Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd., highlighting its strong market position. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.

What is the sector benchmark P/E for healthcare?

Ans. The sector benchmark P/E median for healthcare is 26.44, with an average of 87.62, providing a context for evaluating company valuations. The relevant peer median P/E is 26.44x. The peer average P/E is 87.62x.

Why is Neuland Laboratories Ltd. share price rising?

Ans. The data confirms a 4.53% price rise for Neuland Laboratories Ltd. today, but it does not establish a specific catalyst for this movement. The stock moved 4.53% during the session.